Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionBelpointe Asset Management LLC
Latest Disclosed Ownership2,213 shares
Latest Disclosed Value $ 1,710,008
Belpointe Asset Management LLC reports 1.56% decrease in ownership of REGN / Regeneron Pharmaceuticals, Inc.

On April 28, 2026 - Belpointe Asset Management LLC filed a 13F-HR form disclosing ownership of 2,213 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $1,710,008 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 2,248 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of -1.56% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 2,213 -35 -1.56 1,710 -1.44 0.0624
2026-01-27 2025-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 2,248 2,248 1,735 0.0627
2025-07-22 2025-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -1,011 -100.00 0 -100.00
2025-05-20 2025-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,011 -959 -48.68 641 -72.55 0.0334
2025-02-13 2024-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,970 127 6.89 2,335 20.49 0.1407
2024-11-13 2024-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,843 54 3.02 1,938 3.03 0.1163
2024-08-02 2024-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,789 475 36.15 1,881 48.81 0.1312
2024-05-08 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,314 985 299.39 1,265 338.89 0.0947
2024-02-13 2023-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 329 -483 -59.48 289 -56.89 0.0254
2023-11-15 2023-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 812 439 117.69 668 149.25 0.0692
2023-08-15 2023-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 373 -669 -64.20 268 -68.69 0.0283
2023-05-15 2023-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,042 -61 -5.53 856 7.67 0.0462
2023-02-08 2022-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,103 -150 -11.97 796 -7.88 0.0481
2022-11-14 2022-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,253 604 93.07 863 124.74 0.0583
2022-08-02 2022-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 649 -4 -0.61 384 -15.79 0.0257
2022-04-28 2022-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 653 -1,122 -63.21 456 -59.32 0.0276
2022-02-15 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,775 -3,525 -66.51 1,121 -65.06 0.0699
2021-11-15 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 5,300 2,842 115.62 3,208 133.48 0.2187
2021-08-09 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 2,458 -2,043 -45.39 1,374 -28.85 0.0989
2021-05-14 2021-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,501 4,080 969.12 1,931 851.23 0.1653
2021-02-16 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 421 2 0.48 203 -13.62 0.0182
2020-11-13 2020-09-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 419 -624 -59.83 235 -63.85 0.0262
2020-11-13 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,058 517
2020-07-20 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,043 -15 -1.42 650 25.73 0.0842
2020-07-20 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,058 -486 -31.48 517 -10.86 0.0905
2020-02-18 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,544 1,544 580 0.0736
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.